2015
Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants.
Chachoua I,
Pecquet C,
El-Khoury M,
Nivarthi H,
Albu RI,
Marty C,
Gryshkova V,
Defour JP,
Vertenoeil G,
Ngo A,
Koay A,
Raslova H,
Courtoy PJ,
Choong ML,
Plo I,
Vainchenker W,
Kralovics R,
Constantinescu SN.
Blood. 2015 Dec 14. pii: blood-2015-11-681932.
2015
A Call for Systematic Research on Solute Carriers.
César-Razquin A,
Snijder B,
Frappier-Brinton T,
Isserlin R,
Gyimesi G,
Bai X,
Reithmeier RA,
Hepworth D,
Hediger MA,
Edwards AM,
Superti-Furga G.
Cell. 2015 Jul 30;162(3):478-87. doi: 10.1016/j.cell.2015.07.022. Review.
2015
Atherosclerosis Susceptibility in Mice Is Independent of the V1 Immunoglobulin Heavy Chain Gene.
Centa M,
Gruber S,
Nilsson D,
Polyzos KA,
Johansson DK,
Hansson GK,
Ketelhuth DF,
Binder CJ,
Malin S.
Arterioscler Thromb Vasc Biol. 2016 Jan;36(1):25-36. doi: 10.1161/ATVBAHA.115.305990. Epub 2015 Nov 12.
2015
Phosphatase and tensin homolog (PTEN) in antigen-presenting cells controls Th17-mediated autoimmune arthritis.
Blüml S,
Sahin E,
Saferding V,
Goncalves-Alves E,
Hainzl E,
Niederreiter B,
Hladik A,
Lohmeyer T,
Brunner JS,
Bonelli M,
Koenders MI,
van den Berg WB,
Superti-Furga G,
Smolen JS,
Schabbauer G,
Redlich K.
Arthritis Res Ther. 2015 Aug 26;17:230. doi: 10.1186/s13075-015-0742-y.
2015
Gene essentiality and synthetic lethality in haploid human cells.
Blomen VA,
Májek P,
Jae LT,
Bigenzahn JW,
Nieuwenhuis J,
Staring J,
Sacco R,
van Diemen FR,
Olk N,
Stukalov A,
Marceau C,
Janssen H,
Carette JE,
Bennett KL,
Colinge J,
Superti-Furga G,
Brummelkamp TR.
Science. 2015 Nov 27;350(6264):1092-6. doi: 10.1126/science.aac7557. Epub 2015 Oct 15.
2015
An inducible retroviral expression system for tandem affinity purification mass-spectrometry-based proteomics identifies MLKL as an HSP90 client.
Bigenzahn JW,
Fauster A,
Rebsamen M,
Kandasamy RK,
Scorzoni S,
Vladimer GI,
Mueller AC,
Gstaiger M,
Zuber J,
Bennett KL,
Superti-Furga G.
Mol Cell Proteomics. 2015 Dec 29. pii: mcp.O115.055350.
2015
Identification of the Ki-1 antigen (CD30) as a novel therapeutic target in systemic mastocytosis.
Blatt K,
Cerny-Reiterer S,
Schwaab J,
Sotlar K,
Eisenwort G,
Stefanzl G,
Hoermann G,
Mayerhofer M,
Schneeweiss M,
Knapp S,
Rülicke T,
Hadzijusufovic E,
Bauer K,
Smiljkovic D,
Willmann M,
Reiter A,
Horny HP,
Valent P.
Blood. 2015 Oct 20. pii: blood-2015-03-637728.
2015
Superoxide Dismutase 1 Protects Hepatocytes from Type I Interferon-Driven Oxidative Damage.
Bhattacharya A,
Hegazy AN,
Deigendesch N,
Kosack L,
Cupovic J,
Kandasamy RK,
Hildebrandt A,
Merkler D,
Kühl AA,
Vilagos B,
Schliehe C,
Panse I,
Khamina K,
Baazim H,
Arnold I,
Flatz L,
Xu HC,
Lang PA,
Aderem A,
Takaoka A,
Superti-Furga G,
Colinge J,
Ludewig B,
Löhning M,
Bergthaler A.
Immunity. 2015 Nov 17;43(5):974-86. doi: 10.1016/j.immuni.2015.10.013.
2015
Clinical features of interleukin 10 receptor gene mutations in children with very early-onset inflammatory bowel disease.
Beser OF,
Conde CD,
Serwas NK,
Cokugras FC,
Kutlu T,
Boztug K,
Erkan T.
J Pediatr Gastroenterol Nutr. 2015 Mar;60(3):332-8. doi: 10.1097/MPG.0000000000000621.
2015
Stimulating translational research: several European life science institutions put their heads together.
Bentires-Alj M,
Rajan A,
van Harten W,
van Luenen HG,
Kubicek S,
Andersen JB,
Saarela J,
Cook SJ,
Van Minnebruggen G,
Roman-Roman S,
Maurer C,
Erler JT,
Bertero MG.
Trends Mol Med. 2015 Sep;21(9):525-7. doi: 10.1016/j.molmed.2015.07.002. Epub 2015 Aug 5.
